Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

JAMA. 2021 Oct 12;326(14):1436-1438. doi: 10.1001/jama.2021.15265.

Authors

Sophie Uyoga¹, Ifedayo M O Adetifa¹, Mark Otiende¹, Christine Yegon², Ambrose Agweyu¹, George M Warimwe¹, J Anthony G Scott¹

Affiliations

¹ KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
² Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.

Abstract

This study examines the prevalence of SARS-CoV-2 antibodies among blood donors aged 16 to 64 years in Kenya from January to March 2021.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Antibodies, Viral / blood*
Blood Donors*
COVID-19 / diagnosis
COVID-19 / epidemiology*
COVID-19 Serological Testing
Female
Humans
Kenya
Male
Middle Aged
Prevalence
SARS-CoV-2 / immunology*
Seroepidemiologic Studies
Young Adult

Substances

Antibodies, Viral